Selected Publications

Diorio C, Myers RM, Li Y, Liu H, Belfer S, DiNofia A, Leahy AB, Newman H, Dolan J, Martinez Z, Elhachimi A, Lindell RB, Mullen C, Li A, Kim J, Teachey DT, Maude SL, Grupp SA, McGuire JL.: Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients. Hemasphere 10: e70337, Apr 2026.

Zheng DJ, Hettinger G, Aftandilian C, Bona K, Caywood EH, Collier AB, Elgarten CW, Gathers C, Ghosh T, Gramatges MM, Henry M, Huang YV, Li Y, Lotterman C, Maloney K, Mian A, Miller TP, Modi A, Mody R, Morgan E, Myers R, Newman H, Ortiz J, Seif AE, Smith C, Stokke J, Wang X, Winick N, Wilkes JJ, Wong V, Aplenc R, Getz KD.: Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort. J Natl Cancer Inst 118: 746-750, Apr 2026.

Rankin AW, Myers RM, Lamble AJ, Hsieh EM, Sankaran H, Chen L, Annesley C, DiNofia AM, Grupp SA, Pulsipher MA, Dolan JG, Bhojwani D, Gardner RA, Shah NN, Rheingold SR.: CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multi-site, retrospective cohort review. Blood Adv Feb 2026.

McNerney KO, Annesley A & Myers RM: Chimeric Antigen Receptor T Cell Therapy Infectious Diseases in the Immunocompromised Child, 2nd Ed. 2026.

Grzywa TM, Neeser A, Ramasubramanian R, Romanov A, Tannir R, Mehta NK, Cossette B, Morgan DM, Goncalves B, Sukaj I, Bergaggio E, Kadauke S, Myers RM, Paruzzo L, Ghilardi G, Cozzone A, Schuster SJ, Frey N, Zhang L, Yousefpour P, Abraham W, Suh H, Ruella M, Grupp SA, Chiarle R, Wittrup KD, Ma L, Irvine DJ.: Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells. Nat Biomed Eng 2026.

Deimundo Roura C, Amrolia P, Ansari M, Bader P, Balduzzi A, Buechner J, Hsieh EM, Myers RM, Ottaviano G, Peters C, Rouce RH, Shah NN, Verneris MR, Kalwak K, Pulsipher MA.: Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental Group. Transplant Cell Ther 2026.

Zheng DJ, Hettinger G, Bender JD, Boulter AC, Cao L, Elgarten CW, Fisher BT, Gathers C, Huang YV, Ko J, Leger KJ, Li Y, Myers R, Narayan HK, Ortiz J, Seif AE, Vasileiadi E, Aplenc R, Getz KD.: National Trends in Dexrazoxane and Cardiovascular Health Care Utilization for Children With Acute Myeloid Leukemia. JAMA Oncol 11: 1545-1548, Dec 2025.

Myers RM, Li Y, Liu H, Mumanachit S, Wang L, Leahy AB, Cain LE, DiNofia AM, Diorio C, Freedman JL, Hunger SP, Maude SL, McClory SE, Rheingold SR, Tasian SK, Wray L, Olson TS, Grupp SA, Bunin NJ, Seif AE, Elgarten CW.: Hematopoietic cell transplantation after CD19-directed CAR T-cell therapy for remission consolidation or relapse treatment in pediatric acute lymphoblastic leukemia. Haematologica Nov 2025.

McGuire JL, Pinto S, Erdogan EN, Li Y, Bhatia A, Oztek MA, Vossough A, Wright JN, Shah R, Carapia NT, Shams N, Westermann C, Taraseviciute A, Yates B, Naik S, Gardner R, Annesley C, Hsieh E, Diorio C, Myers R, Epperly R, Talleur A, Shalabi H, Shah N, Gust J.: Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies. Neurology 105: e214086, Oct 2025.

Seif AE, McDonough SL, Becker-Haimes EM, Oranges KE, Clerico D, Hartman J, Rodock K, Schwartz LA, Elgarten CW, Myers RM, Puszczynski RO, Rheingold SR, Stern JW, Jubelirer TF, Armideo EA, Evageliou NF, Randall RJ, Bernt KM, Reilly AF, Tasian SK, Diamant RK, Fisher BT, Getz KD, Aplenc R.: AML Care at Home: An Evidence-Based Toolkit to Personalize the Care Setting for Recovery From Pediatric AML Chemotherapy. JCO Oncol Pract Sep 2025.